Highlights from the Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy. Metabotropic glutamate receptors as therapeutic targets.
The study of metabotropic glutamate receptors (mGluRs) is one of the fastest growing areas of neuropharmacology. The Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy, encompassed more than 80 oral presentations and 70 poster presentations. The role of mGluRs in various physiological and pathological conditions, such as learning and memory, modulation of sensory inputs, control of movement, schizophrenia, anxiety, seizures, addiction to drugs, neurodegeneration and developmental regulation of synaptic circuits, was discussed.
Guitart
X
X
Prous Science Medical Information Deparment. journals@prous.com
Khurdayan
V K
VK
D000818:Animals; D001008:Anxiety Disorders / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008024:Ligands; D009369:Neoplasms / Q000188:drug therapy / Q000209:etiology; D018696:Neuroprotective Agents / Q000494:pharmacology; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology; D040921:Stress Disorders, Traumatic / Q000188:drug therapy / Q000209:etiology; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000209:etiology
D008024:Ligands; D018696:Neuroprotective Agents; D018094:Receptors, Metabotropic Glutamate